|
RALGPS2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.77206999999457E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.773240E-04 |
| Normal-vs-Stage2 |
1.2245999999605E-06 |
| Normal-vs-Stage3 |
1.175780E-03 |
| Normal-vs-Stage4 |
8.807800E-04 |
| Stage1-vs-Stage2 |
1.323990E-02 |
| Stage1-vs-Stage3 |
8.130200E-01 |
| Stage1-vs-Stage4 |
4.772600E-01 |
| Stage2-vs-Stage3 |
2.071600E-02 |
| Stage2-vs-Stage4 |
3.074600E-01 |
| Stage3-vs-Stage4 |
4.108400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.370100E-04 |
| Normal-vs-AfricanAmerican |
1.797940E-02 |
| Normal-vs-Asian |
1.39570000001754E-06 |
| Caucasian-vs-AfricanAmerican |
8.407200E-01 |
| Caucasian-vs-Asian |
4.739400E-03 |
| AfricanAmerican-vs-Asian |
1.140170E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.442500E-04 |
| Normal-vs-Female |
1.51624999999989E-05 |
| Male-vs-Female |
6.199600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.476130E-03 |
| Normal-vs-Age(41-60Yrs) |
3.89460000005393E-06 |
| Normal-vs-Age(61-80Yrs) |
3.828600E-04 |
| Normal-vs-Age(81-100Yrs) |
3.183000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.329190E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
5.910800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.729800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.374800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.375600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.961600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
9.095600E-01 |
| Classical-VS-Follicular |
2.21940000000309E-06 |
| Classical-VS-Other |
8.140200E-01 |
| Classical-VS-Normal |
4.793700E-04 |
| Tall-VS-Follicular |
6.177700E-02 |
| Tall-VS-Other |
7.987400E-01 |
| Tall-VS-Normal |
2.802100E-02 |
| Follicular-VS-Other |
4.606600E-01 |
| Follicular-VS-Normal |
8.6965999956945E-08 |
| Other-VS-Normal |
6.846000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.49929999998722E-06 |
| Normal-vs-N1 |
8.18580000000457E-05 |
| N0-vs-N1 |
6.923800E-01 |
|
|
